Audit-ready data. Capital efficiency. Diverse Populations. Your gateway to APAC.
From first-in-human through Phase II, and on to pivotal Phase III, biotech leaders demand trials that deliver reliable data, regulatory confidence, and investor readiness.
Southern Star Research provides senior-level expertise and hands-on continuity in Australia and the Asia-Pacific to guide your program smoothly from strategy to successful delivery. We anticipate challenges early, generating regulator-ready data that stands up to FDA, EMA, PMDA, and Health Canada scrutiny.
Unlock speed, savings, and global data with Australia’s most trusted CRO.
Biotech clients choose Australia and the broader APAC region for trials that move faster, cost less, and generate regulator-ready data. We leverage this unique landscape to propel your program forward with unparalleled efficiency and quality.
Secure lower costs up to 60% lower than the US or EU, supported by advantageous R&D tax incentives.
Leverage Australia’s predictable, globally-aligned and streamlined research conditions.
Achieve shorter timelines as little as 4–8 weeks from submission to site initiation.
Our trials generate data accepted by major international regulatory bodies.
Our approach
Proactive planning and precision drive your trial's success.
Southern Star Research specializes in guiding small and mid-sized biotech companies through complex early-phase clinical trials. If you are seeking a collaborative and experienced partnership that focuses on generating quality data while anticipating regulatory and investor needs we deliver the stability of a leader and the agility of a specialist.
Therapeutic breadth
Your indication, our insight: proven expertise across early-phase programs.
Since 2010, we’ve successfully supported trials in a wide range of therapeutic areas. Our team’s depth of experience and scientific acumen allow us to proactively identify and navigate complexities, adapt swiftly, and generate data that stands up to global scrutiny.
Knowledge center
Deepen your understanding: navigate and accelerate your clinical development. Gain a deeper understanding of critical topics in clinical research and the Australia-APAC advantages. We act as your trusted advisors, delivering valuable insights to strengthen your approach to early-phase clinical programs.
The Southern Star Research difference
Experience the unique advantages of partnering with Southern Star Research.
As Australia’s leading independent CRO, we combine the capabilities of a full-service global partner with the agility, senior access, and focused expertise of a mid-sized specialist.
Direct access to experienced leaders ensures strategic guidance and consistent decision-making throughout your trial.
Our streamlined structure allows for greater flexibility and faster adaptation to evolving program needs.
We identify protocol friction, site risks and regulatory bottlenecks early: before they consume your timeline or your budget.
Expertise in Australia’s unique clinical trial environment delivers internationally recognized data for major regulatory bodies, accelerating your path to global approvals.
Partner with Southern Star Research.
Discover why small and mid-sized biotechs, pharmaceutical and medical device companies worldwide choose Southern Star Research. Let’s talk about how to move your early-phase program forward with the speed, data quality, and senior accountability your investors and regulators expect.
Connect with us: your opportunity to engage with industry leaders.
Connect with our experts and industry leaders at upcoming conferences, workshops, and speaking engagements.
U.S – Miami, Texas, Utah
Feb 28, 2026 – Mar 14, 2026
Miami Beach, United States
Mar 02 – 03, 2026
Washington USA
Apr 21 – 24, 2025
